Search
Searching with a thematic focus on HIV and health systems, HIV and AIDS, Donors
Showing 1-10 of 43 results
Pages
- Document
Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection
Wiley Online Library, 2011Much of the funding mobilised for the global response to HIV has supported successful expansion in antiretroviral therapy (ART) access, but funding is now at a critical juncture as the global financial crisis bites and funders hesitate. This paper considers the implications of faltering finances for universal ART access and argues for additional funding, used efficiently.DocumentAddressing HIV and AIDS in the workplace: lessons learnt from civil society organisations and donors
STOP AIDS NOW!, 2009For a number of years, STOP AIDS NOW! and its partners have been investing in stimulating workplace responses among civil society organisations (CSOs) to HIV and AIDS. This report, published by STOP AIDS NOW!, summarises the lessons learnt, and draws on over 40 documents that have been produced detailing the work of STOP AIDS NOW! and its partners.DocumentHIV drug policies and south markets: settling controversies
Future Medicine, 2009Despite progress, antiretroviral therapy coverage in low- and middle-income countries remains poor: only 31% of HIV-infected people in need were receiving treatment in 2007.DocumentFinancing for HIV, AIDS, TB and malaria in Uganda: An equity analysis
EQUINET: Network for Equity in Health in Southern Africa, 2009Global health initiatives (GHIs) are an emerging and global trend in health that focus on partnerships. The introduction of GHIs in Uganda has had significant impacts on the overall financing of the health system, though there has been no assessment of their impact on equity in health sector financing in Uganda.DocumentThe effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS control
Health Policy and Planning, 2009This paper, published by the Health Policy and Planning journal, reviews country-level evidence about the impact of global health initiatives (GHIs), which have had profound effects on recipient country health systems in middle and low income countries.DocumentThe Global Fund: managing great expectations
The Lancet, 2004This paper published in the Lancet, tracks early implementation experiences of the Global Fund to Fight AIDS, Tuberculosis and Malaria in four African countries: Mozambique, Tanzania, Uganda, and Zambia. Interim findings are based on interviews with 137 national-level respondents. The paper finds that:DocumentNational health accounts Rwanda 2006 with HIV/AIDS, malaria, and reproductive health subaccounts
Health Systems 20/20, 2008This report reviews Rwanda’s National Health Accounts (NHA) from 2006. In addition, Rwanda has carried out multiple NHA subaccounts: for HIV and AIDS, malaria, and reproductive health (RH). NHA provide trend data that allow policymakers to understand the current and future financing needs of the country’s health care system.DocumentToolkit for mainstreaming HIV and AIDS in the education sector: guidelines for development cooperation agencies
United Nations Girls' Education Initiative, 2008HIV and AIDS mainstreaming in the education sector ensures that addressing HIV and AIDS is not an add-on or a separate activity but an integral part of education sector policies, strategies and actions.DocumentSaving lives now: female condoms and the role of US foreign aid
Center for Health and Gender Equity, 2008This report from the Centre for Health and Gender Equity outlines the importance of the female condom in preventing the spread of HIV.DocumentMissing the target #3: stagnation in AIDS treatment scale up puts millions of lives at risk
International Treatment Preparedness Coalition, 2006This update report from the International Treatment Preparedness Coalition (ITPC) shows that the global effort to provide universal access to HIV treatment is stagnating. Despite progress in some areas it looks like the commitment to achieving universal access to treatment by 2010 will be missed by over 5 million people.Pages
